Development and Validation of a Liquid Chromatography–tandem Mass Spectrometry Method for the Determination of Xanthinol in Human Plasma and Its Application in a Bioequivalence Study of Xanthinol Nicotinate Tablets

Hua-qing Liu,Meng-xiang Su,Bin Di,Tai-jun Hang,Ying Hu,Xiao-qin Tian,Yin-di Zhang,Jian-ping Shen
DOI: https://doi.org/10.1016/j.jchromb.2008.07.045
IF: 3.318
2008-01-01
Journal of Chromatography B
Abstract:A sensitive, rapid liquid chromatographic–electrospray ionization mass spectrometric method for the determination of xanthinol in human plasma was developed and validated. Xanthinol nicotinate in plasma (0.5mL) was pretreated with 20% trichloroacetic acid for protein precipitation. The samples were separated using a Lichrospher silica (5μm, 250mm×4.6mm i.d.). A mobile phase of methanol–water containing 0.1% formic acid (50: 50, v/v) was used isocratically eluting at a flow rate of 1mL/min. Xanthinol and its internal standard (IS), acyclovir, were measured by electrospray ion source in positive selected reaction monitoring mode. The method demonstrated that good linearity ranged from 10.27 to 1642.8ng/mL with r=0.9956. The limit of quantification for xanthinol in plasma was 10.27ng/mL with good accuracy and precision. The mean plasma extraction recovery of xanthinol was in the range of 90.9–100.2%. The intra- and inter-batch variability values were less than 4.8% and 7.9% (relative standard deviation, R.S.D.), respectively. The established method has been successfully applied to a bioequivalence study of two xanthinol nicotinate tablets for 20 healthy volunteers.
What problem does this paper attempt to address?